Peptide Decoding
New?New to peptides?Start here →
Decoding

Irisin_Dosage, benefits & legal status

Also known as FNDC5 fragment, fibronectin type III domain containing 5 fragment

Published August 24, 2026

The exercise-in-a-pill myokine, and a decade-long argument about whether the tests for it work.

Fat loss & metabolicMyokine (exercise-induced)Research only
DoseResearch only
FrequencyNot established
RouteUnder the skin (subcutaneous)
StatusResearch only
CycledNot established

Common vial size is what vendors typically sell, not a recommendation. Enter your own vial in the calculator.

See how this dose compares across the library →

01

What is Irisin?

Plain language first. The technical label stays, but it never stands alone.

Overview

The exercise-in-a-molecule story. The molecule seems to be real, and the blood tests used to build the case for it were measuring the wrong thing.

The technical version

Irisin, the proteolytically cleaved extracellular fragment of FNDC5, proposed as an exercise-induced myokine driving thermogenic browning of white adipose tissue. Detection by commercial polyclonal ELISA has documented cross-reactivity with non-specific serum proteins. Presence confirmed by tandem mass spectrometry. No published human administration trial.

What it's used for

Sold for fat loss and metabolic health as a way to copy the effects of exercise.

02

How does Irisin work?

What it does in the body, and where.

Irisin is the best documented case in this library of an entire literature resting on a faulty measurement.

  1. 01
    The 2012 claim
    Irisin was described as cleaved from the muscle protein FNDC5 during exercise and reported to drive browning of white fat, which would make it a chemical version of a workout.
  2. 02
    The antibodies were measuring something else
    A 2015 paper in Scientific Reports titled irisin a myth rather than an exercise-inducible myokine tested four commercial polyclonal antibodies and found prominent cross-reactivity with unrelated serum proteins, with no bands of the expected size in any biological sample. The authors wrote that this called into question all previous data obtained with commercial ELISA kits.
  3. 03
    Mass spectrometry then found it after all
    A 2015 Cell Metabolism paper detected and quantified circulating human irisin by tandem mass spectrometry, which is a more specific method. The molecule appears to exist.
  4. 04
    The measurement problem did not go away
    A 2020 follow-up reported that available antibodies still bind non-specific serum proteins and that the mass spectrometry approach requires multi-step preparation introducing uncontrolled variation, and issued an explicit warning against measuring circulating irisin with available methods.
03

What else is it used for?

Each use below carries its own evidence level. Approved means regulators have cleared it for that purpose. Investigational means it is in trials. Early research means it is being studied and is not established.

  • Browning of white fat and energy expenditureEarly research
  • Insulin sensitivityEarly research
  • Bone densityEarly research
  • Replacing the metabolic effects of exercisenone

The published record

Research index

3,151

Papers and trials about Irisin

338 papers tagged human · 152 not reviews or lab · 13 clinical trial publications

81 registered trials · 1 with posted results

Furthest stage reached: Published trials only, 13 clinical trial publications, no phased trial registered

Compare this against the whole library →

In animals247
In the lab40
Reviews110
Senior author shareSpread across many groups

Evidence summary

Counted from Europe PMC indexing, not read by a person; a human tag can land on reviews, commentary or lab papers; clinical trial publications is the narrower count. 500 papers and 81 trials indexed in detail.

Irisin vial rendering
Compound field notes

At a glance

Four things to know about Irisin

01

Evidence

Research only

02

Category

Weight loss and metabolic

03

Common vial

Varies

04

Half-life

Nothing published

04

How much, and do you cycle it?

The range, and whether you take breaks.

Research only, not established. Not established No range

No schedule has been studied for this compound in people.

Compare this against the whole library →

05

How long does it stay in the body?

The half-life, and where the figure comes from.

Nothing publishedNo figure

No half-life has been published for administered irisin in people. Given the documented difficulty of measuring it in blood at all, any figure quoted deserves scrutiny about how it was measured.

You can compare this against the whole library to see where it sits.

06

How do I dose and price it?

Enter your vial and your dose. Pick a mix. We show the draw and the cost.

The vial holds a fixed amount of drug. Adding more water does not make more drug, it just spreads it thinner, so you draw a bigger number on the syringe for the same dose.

Your vial size (mg)
Enter the amount printed on your label.
What you paid per vial
$
Used for cost per dose only.
Your dose (mcg)
Commonly referenced range: 100 up to 500 mcgCommunity practice

Choose your mix

your own mL
units · —
Enter your own volume

Measuring the water1 mL = one full 100-unit syringe.

YOUR DRAW0 / 100 units
07

How do you store it?

Before mixing, and after.

Dry powder in the freezer or fridge. Once mixed, fridge, and use within about a month.

Unmixed lyophilized Irisin keeps for a long time cold. Once you add water the clock starts: most reconstituted vials hold up for roughly 28 to 30 days at fridge temperature. Keep it out of light, and do not freeze it after mixing.

08

What are the side effects and cautions?

Known cautions and warnings for this compound.

Who should avoid it

Check these before anything else.
  • Pregnancy or breastfeeding
  • Anyone treating this as a substitute for exercise, which no study supports
  • Anyone who wants established safety data, because none exists for this compound in humans

Stop and get help

These are emergencies. Seek care.
  • Signs of an allergic reaction, including spreading hives, facial or throat swelling, or trouble breathing
  • Redness, heat, or pus at the injection site, which can signal infection
  • Anything unusual, since there is no known safety profile to compare it against

Common effects

Expected, and usually mild.
  • Unknown. No study has recorded what this commonly causes in people
  • Redness, soreness, or a small bump at the injection site

Where this page says nothing is established, that means nobody has studied it, not that a compound is safe.

09

Is Irisin approved?

And where the numbers on this page come from.

No. Irisin is not approved for any use, anywhere. It is sold labeled for laboratory research only, and there is no legal route to buy it for human use.

  • Approval status
    Research only
  • Route
    Under the skin (subcutaneous)
  • Checked
    24 August 2026
  • Dose
    From community reports. No regulator or trial established this dose.
  • Vial size
    From what vendors typically list; not a recommendation.
  • Sources
    None traced yet.

What has happened recently

We have not yet written a full regulatory note for this compound. The status above is current as of the date shown.

Guides for this compound

Sources

No primary source has been traced for this compound yet. Treat everything on this page as unverified until one is. How we grade evidence

Beyond these, 581 records are indexed. Browse the records